Portfolio Update

RNS Number : 3072O

Intl. Biotechnology Trust PLC

16 May 2018

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 30 April 2018

Net Assets	£217m
Net Assets per share	579p
Share price	556p
Total value of unquoted investments	£23m
Total number of portfolio companies	90
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Celgene	6.0
Neurocrine	4.2
Biogen	4.2
Array	3.9
Sage	3.8
Genmab	3.8
Adamas	3.7
Regeneron	3.7
Morphosys	3.7
Vertex	3.5
	-----------
Total	40.5

Geographical Allocation	% NAV
US & Canada	86
Europe & UK	14
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	91
Unquoted	9
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	35
Mid Cap =USD1-10BN	40
Small Cap <USD1BN	25
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	41
CNS	15
Rare diseases	12
Inflammation	6
Ophthalmology	6
Infectious Diseases	4
Metabolic	3
Medtech	2
Other	11
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

16 MAY 2018

 

END

 

 

PFUBDGDUCDBBGIL